All News

A roadmap for cohering patient perspectives.

Industry must continue research and development to combat the pandemic.

Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.

New accelerator will develop products and solutions with the use of digital, data, and AI.

Investments setting up sector for future success that could one day rival its US counterpart.

Approval of Medicare and Medicaid coverage for digital therapeutics represents next step in advancing care for mental health patients.

Experienced physician with in-depth expertise in clinical development and immuno-oncology.

New senior executive brings 25 years of HR leadership and pharma industry experience.

Rise in demand for sustainable practices forces industry to be more proactive.

New data emerges from release of IQVIA's U.S. Medicines Trends 2022 Report.

Looking to the past reminds industry of great strides taken in clinical research for patients.

Despite the rapid innovation of machine learning, correct protocols to ensure compliance and trustworthiness must be considered.

How early stage can help set you up for big stage.

Collaboration reinforces value of connecting proprietary and third-party data.

Continued push for latest technology in biopharma will advance collection of patient data.

Updated guidance reflects progress of ongoing dialog between biopharma companies and investors toward achieving more effective ESG communications.

Acquisition will extend UBC's services to include an affordability solution.

ESG Evaluation names Sanofi as one of the most sustainability-committed companies.

Obstacles in data exchange remain for industry.

Partnership will utilize Medable's trial software platform to enhance access.

COVID-19 response, global workforce both among highlights.

Monoclonal antibody manufacturing site will help deliver innovative medicines to patients around the world.

Scientific vacancies in the UK are up 58% in 2021 compared to 2020, says report.

Funding brings total investment to $123 million.

Indegene’s 2021–22 survey on the digital habits of HCPs across major regions provides some answers to pharma marketers looking to boost their post-pandemic physician engagement campaigns.

Pharma R&D return on investment rises to highest level since 2014.

In a highly unusual decision for a therapy approved by FDA, CMS has taken action to limit prescribing and use of Biogen’s new and controversial Alzheimer’s treatment Aduhelm.